ConferencePharmacoepidemiology and Drug Safety · July 1, 2026
Purpose: Within one week of the Food and Drug Administration granting the COVID-19 vaccine Emergency Use Authorization, the HERO-Together study launched. We describe how the study utilized novel methods for streamlined enrollment and longitudinal data coll ...
Full textCite
ConferenceAm J Prev Cardiol · June 2023
OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice. The objective of this analysis was to determine how Lp(a) testing is used in clin ...
Full textLink to itemCite
ConferenceInt J Infect Dis · April 2023
OBJECTIVES: To determine whether hydroxychloroquine (HCQ) is safe and effective at preventing COVID-19 infections among health care workers (HCWs). METHODS: In a 1: 1 randomized, placebo-controlled, double-blind, parallel-group, superiority trial at 34 US ...
Full textLink to itemCite
ConferenceStroke · February 2023
Introduction:
Atrial fibrillation (AF) is a major risk factor for cerebral ischemic stroke. However, it is not known whether AF predicts the development of central retinal artery occlusion (CRAO), a f ...
Full textCite
ConferenceCirculation · March 5, 2019
Introduction:
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline uses lower clinic and out-of-clinic BP thresholds to define hypertension compar ...
Full textCite
ConferenceCirculation · March 5, 2019
Background:
Endothelin-1 (ET-1) is a vasoconstrictive peptide with cerebral action, also associated with the degree of atherosclerosis. Previous research found that estrogen has inhibitory effect on E ...
Full textCite